Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer - Thailand PR News

 - [Banking](https://thailandbusinessnews.net/category/banking/)
- [Companies](https://thailandbusinessnews.net/category/companies/)
- [Economy](https://thailandbusinessnews.net/category/economy/)
- [Press Releases](https://thailandbusinessnews.net/category/press-release/)
    - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/)
- [Tech](https://thailandbusinessnews.net/category/tech/)
- [Tourism](https://thailandbusinessnews.net/category/tourism/)

    - [Press Release](https://thailandbusinessnews.net/category/press-release/)

# Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

   #####  Up next

  ###### [Video: CEO presentation at Minesto's Capital Market Day 2024](https://thailandbusinessnews.net/press-release/video-ceo-presentation-at-minestos-capital-market-day-2024/)

  Published on 17 December 2024 #####  Author

#####   [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/)

  ##### Tags

- [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/)

CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ — Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The trial showed a threefold increase in the objective response rate (ORR) for the MS-20-Keytruda group (75%) compared to Keytruda alone (25%). Additionally, the median progression-free survival (PFS) for MS-20 patients improved from 4.5 months to over 12 months, with a complete response (CR) rate of 12.5%.

Enhancing Immunotherapy with MS-20

MS-20, developed by Microbio, is a microbiome-based postbiotic designed to improve cancer immunotherapy by modulating the gut microbiome. "The results support MS-20’s potential to reshape the microbiome and enhance Keytruda’s effectiveness in treating advanced NSCLC," said Dr. Wan-Jiun Chen, Executive VP of Research &amp; Development at Microbio. "Currently, hundreds of ongoing trials are aimed to find novel therapeutic agents for improving the efficacy of cancer immunotherapy, and this proof-of-concept trial supports the use of MS-20 in such application."

This randomized, double-blind, placebo-controlled trial involved 15 patients, with 12 analyzed in the modified intent-to-treat (mITT) population (ClinicalTrials.gov ID: NCT04909034). Of the 8 patients receiving MS-20 and Keytruda, 6 (75% ORR) responded positively, including 1 with an ongoing CR lasting over 22 months and 5 with partial responses (PR). In contrast, only 1 of 4 patients in the placebo and Keytruda group showed a PR (25% ORR). The median PFS for the MS-20-Keytruda group was over 12 months, compared to 4.5 months in the placebo group.

Scientific Insights and Next Steps

Preclinical research published in Gut Microbes earlier this year supported these findings, showing that[ ](https://www.tandfonline.com/doi/10.1080/19490976.2024.2380061?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%2520%25200pubmed)[MS-20 enhances immune responses by increasing effector CD8 T cells in the tumor microenvironment](https://www.tandfonline.com/doi/10.1080/19490976.2024.2380061?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%2520%25200pubmed). Microbio plans to use these results to pursue global collaborations and further its microbiome-based cancer immunotherapy platform.

About Microbio Co., Ltd.

Microbio (MB, Est. 2000) is a company focused on immune, oncology and metabolic diseases. In addition, MB is specialized in research and development into microbiome via its unique microbial pharmaceutical technology platforms. Its proprietary library with hundreds of unique anaerobic commensal bacteria metabolites has obtained significant findings in treatment of immune, oncology and metabolic diseases which takes it a further step into next-generation microbiome-based therapeutics.

About MS-20

MS-20 is a postbiotic developed through Microbio’s Symbiota™ fermentation technology involving symbiotic fermentation with multi-strain probiotics under an anaerobic condition. It is clinically proven to alleviate chemotherapy side effects and enhance immunotherapy efficacy. In 2024, MS-20 received an independent/self-affirmed GRAS status in the U.S. and is used in various food and beverages, including specialized medical nutrition products.

For more information, visit[ ](http://www.twmicrobio.com/)[www.twmicrobio.com](http://www.twmicrobio.com/) or meet the team at the JPMorgan Healthcare Conference in San Francisco from January 13-16, 2025.

[Source link ](https://www.prnasia.com/story/archive/4579356_HK79356_0?rand=89749)

```
This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network
```

  #####  You May Also Like

  [](https://thailandbusinessnews.net/press-release/corero-network-security-enhances-uk-dedicated-servers-ddos-defense-with-high-performance-upgrade/) ## Corero Network Security Enhances UK Dedicated Servers' DDoS Defense with High-Performance Upgrade

  UK Dedicated Servers Strengthens Partnership with Corero as First EMEA Adopter of New…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- January 23, 2025

   [](https://thailandbusinessnews.net/press-release/zhang-xinyuan-a-chinese-gender-relationship-expert-leads-thousands-of-women-to-challenge-the-guinness-world-records/) ![Zhang Xinyuan, a Chinese gender relationship expert, leads thousands of women to challenge the Guinness World Records](https://i0.wp.com/r2.thailandbusinessnews.net/2025/10/caption_Guinness_World_Record_award_ceremony__Zhang_Xinyuan__right.jpg?resize=260%2C140&ssl=1 "Zhang Xinyuan, a Chinese gender relationship expert, leads thousands of women to challenge the Guinness World Records")

- [Press Release](https://thailandbusinessnews.net/category/press-release/)

 ## Zhang Xinyuan, a Chinese gender relationship expert, leads thousands of women to challenge the Guinness World Records

  BOAO, China, Oct. 13, 2025 /PRNewswire/ — In 2025, the Boao Forum…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- October 13, 2025

   [](https://thailandbusinessnews.net/press-release/growvana-and-the-beachwaver-co-announce-strategic-partnership-to-expand-across-digital-and-retail-commerce/) ## Growvana and The Beachwaver Co. Announce Strategic Partnership to Expand Across Digital and Retail Commerce

  The partnership brings together one of beauty’s most influential brands with the…

- [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire")
- March 26, 2026

 ##### Most Read

- [![Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"") [Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"")
- [![Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64") [Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64")
- [![Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium") [Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium")
- [![Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries") [Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries")
- [![GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services") [GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services")
- [![600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028") [600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028")

##### Subscribe via Email

 Enter your email address to subscribe and receive notifications of new posts by email.

  Email Address

       Subscribe

  [](https://thailandbusinessnews.net/press-release/cellebrite-expands-global-digital-community-the-101-for-digital-forensics-and-investigative-professionals/) ![Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals](https://i0.wp.com/mmx.prnasia.com/media/MS1775952/Cellebrite-Logo.jpg?resize=260%2C140&ssl=1 "Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals")

 ## Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals

  Purpose-built platform connects customers worldwide with peers and Cellebrite experts…

   [](https://thailandbusinessnews.net/press-release/eightco-holdings-nasdaq-orbs-reports-total-holdings-of-approximately-380-million-includes-openai-beast-industries-more-than-16000-eth-and-nearly-302-million-wld-tokens-2/) ![Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately 0 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens](https://i0.wp.com/mmx.prnasia.com/media/MS695659/Eightco-Logo.jpg?resize=260%2C140&ssl=1 "Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately 0 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens")

 ## Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $380 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens

  Eightco treasury composition as of September 16, 2026: $90M OpenAI equity (indirect),…

   [](https://thailandbusinessnews.net/press-release/theres-no-one-size-fits-all-for-treating-older-adults-with-cancer-according-to-new-nccn-patient-resource/) ## There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource

  New guideline for patients and caregivers explains the importance of assessments to…

   [](https://thailandbusinessnews.net/press-release/loccitane-group-achieves-a-new-milestone-in-its-b-corp-certification-journey/) ![L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey](https://i0.wp.com/mmx.prnasia.com/media/MS1989037/Key_Visual_Vertical_2_No_Border-T.jpg?resize=260%2C140&ssl=1 "L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey")

 ## L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey

  Progress is measured not only by what is achieved, but by the…
<!-- Performance optimized by Docket Cache: https://wordpress.org/plugins/docket-cache -->
